Epichem, page-26

IMO price is slipping as management set an expectation that they would provide regular updates on human and dog trials however they have not been doing this. This lack of information however does not mean the trials are failing or passing. Just a case of management not estimating the timing of information properly.

Yes company has other income streams but whether the share price moves up or down (significantly) will be due to the outcome of the trials. I doubt the other income streams will have as much impact as the trial outcomes in the ST to MT.

All other factors will have an input but not so much so as the trials. The question I ask myself is do I believe the outcome of the trials will be positive or negative. I think positive but admit I am bias as I hold shares.